These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32432775)

  • 61. Long-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium.
    Schottler J; Randoll N; Lucius R; Caliebe A; Roider J; Klettner A
    Exp Eye Res; 2018 Jun; 171():1-11. PubMed ID: 29522724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Experimental evaluation of aniline and methyl blue for intraocular surgery.
    Haritoglou C; Priglinger S; Liegl R; May CA; Eibl K; Thaler S; Kampik A; Schuettauf F
    Retina; 2009 Oct; 29(9):1266-73. PubMed ID: 19934821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
    Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
    J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells.
    Brar VS; Sharma RK; Murthy RK; Chalam KV
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):507-11. PubMed ID: 20028259
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant.
    Huhtala A; Rönkkö S; Teräsvirta M; Puustjärvi T; Sihvola R; Vehanen K; Laukkanen A; Anttila J; Urtti A; Pohjonen T; Uusitalo H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2216-23. PubMed ID: 19136700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BNIP3-mediated Autophagy Induced Inflammatory Response and Inhibited VEGF Expression in Cultured Retinal Pigment Epithelium Cells Under Hypoxia.
    Chen Y; Yan Q; Xu Y; Ye F; Sun X; Zhu H; Wang H
    Curr Mol Med; 2019; 19(6):395-404. PubMed ID: 31072291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Photoprotective effects of cranberry juice and its various fractions against blue light-induced impairment in human retinal pigment epithelial cells.
    Chang CH; Chiu HF; Han YC; Chen IH; Shen YC; Venkatakrishnan K; Wang CK
    Pharm Biol; 2017 Dec; 55(1):571-580. PubMed ID: 27937080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monounsaturated oleic acid modulates autophagy flux and upregulates angiogenic factor production in human retinal pigment epithelial ARPE-19 cells.
    Chang YC; Lin CW; Chang YS; Chen PH; Li CY; Wu WC; Kao YH
    Life Sci; 2020 Oct; 259():118391. PubMed ID: 32891610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endoplasmic reticulum stress and autophagy contribute to cadmium-induced cytotoxicity in retinal pigment epithelial cells.
    Zhang L; Xia Q; Zhou Y; Li J
    Toxicol Lett; 2019 Sep; 311():105-113. PubMed ID: 31054874
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of Sulfated Fucans from
    Dörschmann P; Kopplin G; Roider J; Klettner A
    Mar Drugs; 2019 Sep; 17(10):. PubMed ID: 31557816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intracameral moxifloxacin: in vitro safety on human ocular cells.
    Kernt M; Neubauer AS; Liegl RG; Lackerbauer CA; Eibl KH; Alge CS; Ulbig MW; A AK
    Cornea; 2009 Jun; 28(5):553-61. PubMed ID: 19421040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium.
    Li Q; Lai KL; Chan PS; Leung SC; Li HY; Fang Y; To KKW; Choi CHJ; Gao QY; Lee TWY
    Colloids Surf B Biointerfaces; 2016 Apr; 140():278-286. PubMed ID: 26764115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epigallocatechin gallate & curcumin prevent transforming growth factor beta 1-induced epithelial to mesenchymal transition in ARPE-19 cells.
    Shanmuganathan S; Sumantran VN; Angayarkanni N
    Indian J Med Res; 2017 Nov; 146(Suppl):S85-S96. PubMed ID: 29578200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model.
    Alexopoulos P; Panoutsopoulou K; Vogiatzis G; Koletsis E; Dougenis D; Tsopanoglou NE
    J Cardiovasc Pharmacol; 2017 Jul; 70(1):34-41. PubMed ID: 28679129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green.
    Yuen D; Gonder J; Proulx A; Liu H; Hutnik C
    Am J Ophthalmol; 2009 Feb; 147(2):251-259.e2. PubMed ID: 18992870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Esculetin Protects Human Retinal Pigment Epithelial Cells from Lipopolysaccharide-induced Inflammation and Cell Death.
    Ozal SA; Turkekul K; Gurlu V; Guclu H; Erdogan S
    Curr Eye Res; 2018 Sep; 43(9):1169-1176. PubMed ID: 29806490
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.
    Zhang Y; Ma A; Wang L; Zhao B
    Ophthalmic Res; 2015; 55(1):1-9. PubMed ID: 26536586
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of VEGF inhibitors on human retinal pigment epithelium under high glucose and hypoxia.
    Bahrami B; Shen W; Zhu L; Zhang T; Chang A; Gillies MC
    Clin Exp Ophthalmol; 2019 Nov; 47(8):1074-1081. PubMed ID: 31265210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parstatin inhibits viability of human retinal pigment epithelium cells: an in vitro cytotoxicity study.
    Gartaganis PS; Cotsiki M; Anastassiou ED; Tsopanoglou NE; Melachrinou MD
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5111-5117. PubMed ID: 32432775
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.